Drug Utilization Research / Trends and comparisons

((A-143)) (A-143) Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

((B-112)) (B-112) Trends in Outpatient Influenza Antiviral Use in US Adults: 2010-2021

((B-113)) (B-113) Changes in Initial Maintenance Inhaler Regimens for Canadian Patients with Chronic Obstructive Pulmonary Disease from 2018-2023: A Multi-Province Analysis

((B-114)) (B-114) Temporal Trends in Clinical Characteristics and Treatment Patterns of Patients with Both CKD and T2D Initiating a GLP-1 RA and SGLT2i: Findings From a Large Database in the United States, 2014-2023

((B-115)) (B-115) Variations in antibiotic use in late premature and term newborns in neonatal care in Sweden 2012-2020

((B-116)) (B-116) Antipsychotic Use Before and After Foster Care Enrollment Among Youth in Medicaid

((B-117)) (B-117) Initial opioid prescriptions for non-cancer patients in Yinzhou China: a retrospective, observational study based on regional medical data during 2011-2023

((B-118)) (B-118) Bibliometric Analysis of Global Research Trends and Themes in ADHD

((B-119)) (B-119) Real-World Utilization Patterns and Adherence to Subcutaneous and Oral Semaglutide in Adults with Type 2 Diabetes Treated in UK Primary Care

((B-120)) (B-120) Optic Neuritis and Corticosteroid Utilization among Patients with Multiple Sclerosis: An Electronic Medical Records Study

((B-121)) (B-121) Yearly Prevalence of Polycystic Ovary Syndrome (PCOS) Diagnosis in the United States and the Uptake of Management Treatment Following Diagnosis in Commercially Insured Women Aged 18-44

((B-122)) (B-122) Real-World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross-Sectional Time Series Analysis

((B-123)) (B-123) Use of Glucagon-like Peptide 1 Agonists (GLP-1's) Among Individuals Undergoing Bariatric Surgery In The United States: A Retrospective Cohort Study

((B-124)) (B-124) Pharmacoepidemiological study about the usage of antidepressants in young adults in Greece

((B-125)) (B-125) Contact with the Health Care System Among Older Adults with HER2-Positive Metastatic Breast Cancer

((B-126)) (B-126) Oral antibiotic use with focus on fluoroquinolones during 2010-2021 in four European countries: Finnish results of the HORIZON-EU project “Real4Reg”

((B-127)) (B-127) Proton pump inhibitor use in infants younger than one year of age: Nationwide Cohort Study Based on the French EPI-MERES Register

((B-128)) (B-128) Medical Cannabis Use in Association with Drugs Associated with Risks of Interaction with Cannabinoids: A Longitudinal Cohort Study

((B-129)) (B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies

((B-130)) (B-130) Initiation of anticoagulants during the COVID-19 pandemic in Sweden: an interrupted time series analysis

((B-131)) (B-131) Trends, Patterns, and Characteristics of Gabapentin Use among Medicare Beneficiaries (2012-2021)

((B-132)) (B-132) Raloxifene Use Over Time Among U.S. Medicare Beneficiaries

((B-133)) (B-133) Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community: A Cross-National Comparison

((B-134)) (B-134) DARWIN EU® - Paracetamol prescribing in Europe: a descriptive analysis of incidence and prevalence rates

((B-135)) (B-135) Trends in Menopausal Hormone Therapy dispensing in Australia between 2014 and 2023

((B-136)) (B-136) Utilization Trends of Methadone and Buprenorphine for Opioid Use Disorder in the US Medicaid population

((B-137)) (B-137) Contemporary Trends in Oral Anticoagulant Use Among Patients with Atrial Fibrillation and Cancer in UK Primary Care

((B-138)) (B-138) Utilization of VMAT2 Inhibitors for Tardive Dyskinesia Among Adult Antipsychotic Users

((C-063)) (C-063) Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020

((C-064)) (C-064) Trends in Polycystic Ovary Syndrome and Its Associated Pharmacological Treatments in the United Kingdom from 1998 to 2023

((C-065)) (C-065) Age-specific Drug Utilization Patterns Among Pregnant Women in Taiwan: A Nationwide Cohort Study

((C-066)) (C-066) Channeling Bias in First-Line Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Individuals with Severe Mental Illness and Diabetes

((C-067)) (C-067) COVID-19 Pandemic and Statin Adherence in Sweden: Insights from Cohort Analyses Before and During the Crisis

((C-068)) (C-068) Expenditure and Utilization on GLP-1 Medications across High-Income Countries: A repeated cross-sectional analysis

((C-069)) (C-069) Comparison of Expenditure and Utilization of Top 25 High-Cost Drugs Across Canada and Comparable Countries

((C-070)) (C-070) Racial and Ethnic Differences in Initiation and Continuation of Treatment Among Medicare Beneficiaries with Opioid Use Disorder from 2010-2019

((C-071)) (C-071) Association Between Opioid Use Disorder (OUD) Treatment Modalities and Opioid-Related Hospitalizations Among Medicare Beneficiaries

((C-072)) (C-072) Treatment Patterns of Immunoglobulin Replacement Therapy Among Patients with Multiple Myeloma in the United States: a Real-World Analysis

((C-073)) (C-073) Barriers and Facilitators to Deprescribing Opioids in High-Risk Older Adults: A comparison based on cirrhosis status

((C-074)) (C-074) The temporal trends of Escherichia coli antimicrobial resistance and antibiotic utilization in Australian Long-Term Care Facilities

((C-075)) (C-075) Evaluating treatment patterns in newly diagnosed Pulmonary Arterial Hypertension patients: First network study in PHederation, the Pulmonary Hypertension federated data network

((C-076)) (C-076) Trends in Postpartum Anti-Obesity Medication Use among Commercially Insured Pregnant Women, 2016-2022

((C-077)) (C-077) Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System

((C-078)) (C-078) Psychotropic Medication Use among Youth with Schizophrenia in Medicaid Foster Care Program

((C-079)) (C-079) Antibiotic Prescribing Trends by Provider Specialty and Drug Class Before and During the COVID-19 Pandemic (2013-2022)

((C-080)) (C-080) Naloxone Prescribing Trends Among Regions and Providers of the United States: Analysis of Medicare Part D Prescriber Data 2013-2022

((C-081)) (C-081) An Algorithm for Mapping the Treatment Sequences of Patients with COPD: Development and Application in a Canadian Cohort.

((C-083)) (C-083) Use of Statins for Primary Prevention among Individuals with Chronic Kidney Disease in The United States: A Cross-Sectional, Time-Trend Analysis

((C-084)) (C-084) Oral Anticoagulant Use by Comorbidity in Long-term Care: A Population-based Cross-Sectional Study

((C-085)) (C-085) Belatacept Use Among U.S. Kidney Transplant Recipients (2011-2020)

((C-086)) (C-086) Evaluating the Impact of GAAT Criteria on the Development of Antimicrobial Resistance in ICU Patients Receiving Parenteral Antimicrobial Therapy

((C-087)) (C-087) DARWIN EU® - Prescription pattern of STOPP section K criteria medication in elderly with and without recurrent falls

((C-088)) (C-088) Patterns of Opioid Reinitiation: Insights from US National Data (2018-2022)

((C-089)) (C-089) Comparison of Opioid Prescribing Before and After Onset of the COVID-19 Pandemic in the USA (2018-2022)

((C-090)) (C-090) Trends in insulin utilization and SARIMA forecasting: A time-series analysis in Greece (2016–2023) using IQVIA dataset

((C-091)) (C-091) Trends in Outpatient Antibiotic Prescribing in the United States using Real World Data from 2020 to 2024

((C-092)) (C-092) Trends in opioid prescribing prior to opioid toxicity inpatient hospitalizations and ED visits in Canada, 2018-2022

((C-093)) (C-093) Treatment patterns in pediatric type 1 diabetes mellitus patients in Taiwan

((C-094)) (C-094) Osteoporosis Pharmacotherapy in people with and without Parkinson’s disease in Finland

((C-095)) (C-095) Trajectories of Osteoporosis Pharmacotherapy among Older Treatment-Naïve Females

((C-096)) (C-096) Trends in the Prescription of Central Nervous System Depressants in Patients with Chronic Obstructive Pulmonary Disease in the United Kingdom Primary Care, 2000 – 2022

((C-098)) (C-098) Trends in the consumption of psychotropic drugs in France, in children, adolescents and young adults between 2012 and 2023

((C-099)) (C-099) Trends in Clinical Prescription Patterns and Selection of Anabolic drugs for postmenopausal women with osteoporosis in Taiwan

((C-100)) (C-100) Prescribing Patterns and Lipid Control Outcomes of PCSK9 Inhibitors in the Greater Bay Area of China

((C-101)) (C-101) A time-trend analysis of psychotropic drug prescription patterns in a Peruvian inpatient population during the COVID-19 pandemic

((C-102)) (C-102) Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study

((C-103)) (C-103) Treatment of Type 2 Diabetes Among Medicare Beneficiaries With and Without Alzheimer’s Disease: A Retrospective Cohort Study

((C-104)) (C-104) Trends in Spironolactone Incidence by Indication among Young Women and Girls in the United States: Quantifying Patterns of On-label and Off-label Prescribing

((C-105)) (C-105) Characterizing Demographics and Comorbidities for New Initiator GLP-1 Patients, 2016 – 2023

((C-106)) (C-106) Trends in Utilization, Spending, and Pricing of Janus Kinase (JAK) Inhibitors in the U.S. Medicaid Program (2011-2023)

((C-107)) (C-107) Investigating Treatment Pathways for Rheumatoid Arthritis in Adult Patients: Insights from Real-World Data

((C-108)) (C-108) Antidepressant use in a nationally representative cohort of older adults: longitudinal use and polypharmacy